Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

A few years ago, my doctor prescribed me high doses of omeprazole (a proton pump inhibitor) to treat acid reflux twice a day. I didn’t have severe symptoms, but an endoscopy showed that the cells in my esophagus were changing toward a cancerous state to protect themselves from the acid flowing up from my stomach. For three months, I took 40mg of omeprazole each morning and evening—a typical over the counter dose is only 20mg daily—and cut out many foods that can cause acid reflux like coffee, alcohol, and my all-time favorite, dark chocolate. The next endoscopy showed my cells…

Read More

✅ This article was reviewed and approved by Shamard Charles, member of our MedShadow Medical Advisory Board. Vickie Hadge wasn’t diagnosed with multiple sclerosis (MS) until more than 10 years after her first symptoms appeared. For that first decade, when she knew something was wrong and she didn’t know what, she took her health into her own hands, adopted a vegetarian diet and took up yoga and meditation. When she was finally diagnosed with MS in 2017, she was prescribed a disease-modifying medication, Copaxone (glatiramer acetate). Since the diagnosis, she says, she has remained relapse-free. For that, she credits both…

Read More